Markets:

Overview

News

Currencies

International

Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

119.72 -13.89 (-10.40%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research

October 20, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:BNTX),(NASDAQ:SGEN),(NASDAQ:MYGN),(NASDAQ:ILMN) EQNX::TICKER_END

Via FinancialNewsMedia

3 Nasdaq-100 Stocks Trading Less Than 10x 2024 Earnings

October 19, 2023

These three Nasdaq-100 stocks can be had for less than 10x 2024 earnings - extra compelling given that Wall Street expects Nasdaq profits will grow next year.

Via MarketBeat

Topics Bonds Economy

3 Undervalued Healthcare Stocks to Watch as Sector Struggles

October 06, 2023

As the healthcare sector slumps, several major stocks, including Zimmer Biomet, Moderna, and Illumina, appear undervalued in contrast to their intrinsic worth.

Via MarketBeat

Illumina, Inc. (NASDAQ: ILMN) is a Leading Gainer in Monday Morning Trading

March 13, 2023

Via Investor Brand Network

Lowey Dannenberg, P.C. is Investigating Illumina, Inc. (NASDAQ: ILMN) for Potential Breaches of Fiduciary Duty by Its Board of Directors

October 04, 2023

From Lowey Dannenberg, P.C.

Via GlobeNewswire

Lowey Dannenberg, P.C. is Investigating Illumina, Inc. (NASDAQ: ILMN) for Potential Breaches of Fiduciary Duty by Its Board of Directors

September 29, 2023

From Lowey Dannenberg, P.C.

Via GlobeNewswire

Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

September 19, 2023

Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only test

From Myriad Genetics, Inc.

Via GlobeNewswire

Agrigenomics Market Is Booming Worldwide : Illumina, LGC, Eurofins USA

July 25, 2023

Stay up-to-date with Agrigenomics Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.

Via SBWire

Next Generation Sequencing Market Projected to Show Strong Growth : Life Technology, Biomatters, CLC Bio, GATC Biotech

July 24, 2023

Get an extensive Next Generation Sequencing Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry.

Via SBWire

A Comprehensive Study Exploring Viral Disease Diagnosis Market : Key Players BioMerieux, Prescient Medicine Holdings, Danaher

July 12, 2023

AMA released Viral Disease Diagnosis Market research study .Check what differences transitions in customer choices may bring?

Via SBWire

Creative Biolabs’ Innovative Microbial Identification Solutions Propel Live Biotherapeutic Research

June 28, 2023

Via Get News

Medical Stocks Waters, Agilent, Illumina Show Growth Potential

June 20, 2023

Medical-sector stocks Waters, Agilent, and Illumina appear to be trading at low valuations relative to their future growth prospects, according to analysts.

Via MarketBeat

Nephroblastoma Pipeline, NDA Approvals, Clinical Trials, and Emerging Drugs (2023) | Companies – Clarity Pharma, Y mAbs Therapeutics, Nova Biopharma, Eli Lilly, Illumina Radiopharma, Recombio and Other

June 16, 2023

Via AB Newswire

Hestia Insight Inc. Signs Letter of Intent With Major Asian-Pacific Health Care Products Distributor

May 10, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Intellectual Property

Will Forced Divesture Of Grail Boost Illumina Shareholder Value?

May 03, 2023

Regulators may force Illumina to divest Grail, which it acquired in 2021. Carl Icahn is also calling for a divestiture. The move could benefit shareholders.

Via MarketBeat

Realtimecampaign.com Discusses Some of the Many Benefits of Genotyping

April 26, 2023

Via Get News

DNA Data Storage Alliance Announces Board Appointments

March 29, 2023

From DNA Data Storage Alliance

Via Business Wire

Next Generation Sequencing Technology Market 2023 Innovation, Application, Future Trends, Outlook by Type, Application and Business Opportunities to 2030

March 28, 2023

Next Generation Sequencing Technology Market Growth and Outlook 2023-2030 SWOT Analysis by Key Players – Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life...

Via SBWire

Universal Sequencing Technology Corporation Launches High-Throughput Solution For Microbial WGS Library Preparation

March 14, 2023

CARLSBAD, Calif. - March 14, 2023 - PRLog -- Universal Sequencing Technology Corporation (UST), a global leader in genomic sequencing innovations, announced today the release of a high throughput...

Via PRLog

Topics Intellectual Property

DNA Sequencing and Service Market May See a Big Move : Abbott Laboratories, Eurofins Scientific, Illumina

March 07, 2023

Stay up-to-date with DNA Sequencing and Service Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.

Via SBWire

Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States

March 02, 2023

Strategic partnership offers a unique combination of diagnostic development and commercialization capabilities to the pharmaceutical industry

From Myriad Genetics, Inc.

Via GlobeNewswire

Home Healthcare Equipment Market Trends, Volume, Growth Strategies Forecast Report 2023

February 16, 2023

Some of the major players profiled in the Home Healthcare Equipment Market report are Abbott Laboratories (US), F. Hoffman-La Roche (Switzerland), QIAGEN (Germany), Thermo Fisher Scientific (US),...

Via SBWire

Topics Economy

Cri-Du-Chat Syndrome Market Demand Trends Size Overview Analysis 2022-2029

February 14, 2023

Global Cri-du-chat Syndrome Market to Witness Huge Growth by Key Players: Centogene AG, Eurofins Scientific, Laboratory Corporation of America Holdings, Quest Diagnostics, PerkinElmer Inc., Natera,...

Via SBWire

New Survey Data Shows Innovation Teams at Large Companies Are Focusing More on Near-Term Initiatives, but Internal Politics and Culture Remain Top Challenges

February 07, 2023

InnoLead has released a 2023 update to its popular Benchmarking Innovation Impact research with KPMG LLP.

Via Newswire.com

Genotek (Yerevan, Armenia), Professor Tamara Sarkisian and Illumina open a world-class genomic laboratory

November 18, 2022

The modern laboratory complex, complete with genomic sequencers and microarray analysis platforms from the U.S. company Illumina, helps solve problems in medical research and agriculture. In addition...

Via PRUnderground

Topics Economy

GRAIL CCGA Discovery Results Published in Cancer Cell Reveal Methylation as Promising DNA Hallmark for Multi-Cancer Early Detection

November 17, 2022

From GRAIL, LLC

Via Business Wire

Universal Sequencing Technology Corporation (UST) partners with TATAA Biocenter to offer Long Read Sequencing Services with TELL-Seq Linked-Read Tech

January 10, 2023

CARLSBAD, Calif. - Jan. 10, 2023 - PRLog -- Universal Sequencing Technology Corporation (UST) announces today, January 10th, 2022, that it has partnered with TATAA Biocenter, one of our key...

Via PRLog

Topics Intellectual Property

Universal Sequencing Technology Corporation Announces High-Throughput Solution For NGS Library Preparation

October 24, 2022

UST releases high-throughput solution enabling second-generation short-read sequencers to produce long-range results in greater capacity.CARLSBAD, Calif. - Oct. 24, 2022 - PRLog -- Universal Sequencing...

Via PRLog

Topics Intellectual Property

Companion Diagnostics Industry to Witness Emergence of Players Including Abbott Laboratories, - bioMerieux, Illumina, Agilent Technologies, and Thermo Fisher Scientific –

October 18, 2022

This press release was orginally distributed by SBWire

Via ReleaseWire

Companion Diagnostics Industry to Witness Emergence of Players Including Abbott Laboratories, - bioMerieux, Illumina, Agilent Technologies, and Thermo Fisher Scientific –

October 18, 2022

London, UK -- (SBWIRE) -- 10/18/2022 -- The latest publication titled Companion Diagnostics – Thematic Research has been added to GlobalData Plc report store. Companion diagnostics (CDx) are molecular...

Via SBWire

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Illumina, Inc. - Common Stock (NQ:ILMN)

Press Releases about Illumina, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today